Abstract
Background/aimsLipid profiles have been changed in numerous chronic conditions. The impact of uveitis on lipid metabolism remains unclear.MethodsThis is a cross-sectional study included 416 patients with non-infectious uveitis (NIU) and 416 healthy subjects. Standard techniques were used to measure total cholesterol (TC), triglycerides (TG), high-density lipoprotein-cholesterol (HDLc), low-density lipoprotein-cholesterol (LDLc) levels. Quantitative optical coherence tomography angiography (OCTA) parameters were obtained from 500 eyes in each group. Correlation analysis examined the relationship between lipid profile and OCTA parameters.ResultsPatients with NIU exhibited significantly elevated TC, TG and LDLc levels compared with controls (p=0.003; p<0.001; p<0.001, respectively). Subgroup analysis revealed that HDLc was significantly lower in Behçet’s disease (p=0.024) compared with controls. Vascular density (VD) in the superficial capillary plexus (SCP), deep capillary plexus (DCP), choriocapillaris and optic disk were significantly decreased in NIU eyes (p<0.05, respectively) compared with controls. HDLc exhibited a significant negative correlation with VDs in the whole and parafovea SCP (r=−0.489, p=0.008; r=−0.480, p=0.0026, respectively), while LDLc showed a significant positive correlation with VDs in the whole and parafovea DCP in NIU patients (r=0.576, p=0.032; r=0.267, p=0.034, respectively).ConclusionsThe lipid profile is altered in NIU, and there are correlations between HDLc and LDLc levels and VD as measured by OCTA. Lipid profile analysis may offer valuable insights into evaluating vascular and metabolic aspects of NIU.
Funder
National Natural Science Foundation of China
Reference25 articles.
1. Sarcoid uveitis: a case report and systematic review of literature;Shen;Adv Ophthalmol Pract Res,2022
2. International Uveitis Study Group (IUSG) Clinical Classification of Uveitis
3. Low levels of total cholesterol, high-density lipoprotein, and apolipoprotein A1 in association with Anticardiolipin antibodies in patients with systemic lupus erythematosus;Lahita;Arthritis Rheum,1993
4. Role of dyslipidemia in accelerating inflammation, autoimmunity, and atherosclerosis in systemic lupus erythematosus and other autoimmune diseases;Wang;Discov Med,2020
5. Lessof MH , Jefferys DB , Lehner T , et al . Corticosteroids and azathioprine: their use in Behet’s syndrome. 1979.